Hydroxyurea inhibits intracellular Toxoplasma gondii multiplication

FEMS Microbiology Letters

Volumn 185, Issue 1, 2000, Pages 79-82

  De Melo, E J T ^a   Mayerhoffer, R O ^a   De Souza, W ^a,b  

^a UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cell cycle; Hydroxyurea; Toxoplasma gondii

Indexed keywords

HYDROXYUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; DRUG EFFECT; HOST PARASITE INTERACTION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; HOST-PARASITE RELATIONS; HYDROXYUREA; MICE; MICROSCOPY, ELECTRON; NUCLEIC ACID SYNTHESIS INHIBITORS; TOXOPLASMA; VERO CELLS;

TOXOPLASMA GONDII;

EID: 0034177316     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00074-4     Document Type: Article

References (15)

1. Morisaki, J.H., Heuser, J.E. and Sibley, L.D. (1995) Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J. Cell Sci. 108, 2457-2464.
2. Nichols, B.A. and O'Connor, G.R. (1981) Penetration of mouse peritoneal macrophages by the protozoan Toxoplasma gondii. Lab. Invest. 44, 324-335.
3. DaMatta, R.A., Seabra, S.H. and De Souza, W. (1998) Further studies on the phagocytic capacity of chicken thrombocytes. J. Submicrosc. Cytol. Pathol. 30, 271-277.
4. Pfefferkorn, E.R. (1990) Cell Biology of Toxoplasma gondii. In: Modern Parasite Biology (Wyler, D.J., Ed.), pp. 26-50. WH Freeman and Company, NY.
5. Melo, E.J.T. and De Souza, W. (1996) Pathway of C6-NBD-Ceramide on the host cell infected with Toxoplasma gondii. Cell Struct. Funct. 21, 47-52.
6. Schwab, J.C., Beckers, C.L.M. and Joiner, K. (1994) The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc. Natl. Acad. Sci. USA 91, 509-513.
7. Melo, E.J.T. and De Souza, W. (1997) Relationship between the host cell endoplasmic reticulum and the parasitophorous vacuole containing Toxoplasma gondii. Cell Struct. Funct. 22, 317-323.
8. Tanabe, K. (1985) Visualization of the mitochondria of Toxoplasma gondii-infected mouse fibroblasts by the cationic permeant fluorescent dye rhodamine 123. Experientia 41, 101-103.
9. Yarbro, J.W. (1992) Mechanism of action of hydroxyurea. Sem. Oncol. 19 (Suppl. 9), 1-10.
10. Simonelli, C., Nasti, G., Vaccher, E., Tirelli, U., Zanussi, S., Depaoli, P., Comar, M. and Giacca, M. (1996) Hydroxyurea treatment in HIV-infected patients. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13, 462-464.
11. Gwilt, P.R. and Trace-well, W.G. (1998) Pharmacokinetics and pharmacodynamics of hydroxyurea. Clin. Pharmacokinet. 34, 347-358.
12. Hofer, A., Ekaren, J.T. and Thelander, L. (1998) Allosteric regulation of Trypanosoma brucei ribonucletide reductase studied in vitro and in vivo. J. Biol. Chem. 273, 34098-34104.
13. Taylor, W.R., Agarwal, M.L., Agarwal, A., Stacey, D.W. and Stark, G.R. (1999) P53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 18, 283-295.
14. Gormley, P.D., Pavesio, C.E., Minnasian, D. and Lightman, S. (1998) Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest. Ophthalmol. Vis. Sci. 39, 1171-1175.
15. Gross, U. and Polh, F. (1996) Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. In: Toxoplasma gondii (Gross, U., Ed.), pp. 247-259. Springer-Verlag, Berlin.